Medscape

As Direct Oral Anticoagulants Face Off in VTE Trial, Apixaban Confirmed as a Safer Option

Apixaban halved the risk for bleeding compared with rivaroxaban in the treatment of acute venous thromboembolism in the ...
MedPage Today

Apixaban Snags a Win in Head-to-Head Trial of Direct Oral Anticoagulants

The COBRRA trial directly tested apixaban and rivaroxaban, the oral anticoagulants most frequently used to treat acute venous thromboembolism. The risk of clinically relevant bleeding came out ...
ahajournals.org

Part 9: Adult Advanced Life Support: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care

In these 2025 Advanced Life Support Guidelines, the American Heart Association provides comprehensive recommendations for the resuscitation and management of adults experiencing cardiac arrest, ...
Canadian Medical Association Journal

Five things to know about ... D-dimer testing in clinical practice

D-dimer testing is useful for excluding venous thromboembolism (VTE), where a low D-dimer level helps exclude deep vein thrombosis (DVT) and pulmonary embolism (PE).[1][1] However, elevated levels are ...
ahajournals.org

Implementing the PREVENT Risk Equation in the 2025 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

ASCVD indicates atherosclerotic cardiovascular disease; BMI, body mass index; BP, blood pressure; CKM, cardiovascular-kidney-metabolic; CVD, cardiovascular disease ...